These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23214161)

  • 21. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
    Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
    Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA
    Neural Plast; 2015; 2015():858251. PubMed ID: 26137324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine augmentation strategy for patients with treatment-resistant depression.
    Gutierrez RL; McKercher RM; Galea J; Jamison KL
    CNS Spectr; 2005 Oct; 10(10):800-5. PubMed ID: 16400242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
    Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
    J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spotlight on lamotrigine in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease.
    Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
    J Clin Psychiatry; 2019 Jun; 80(4):. PubMed ID: 31163106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
    Lin PY; Su KP
    J Clin Psychiatry; 2007 Jul; 68(7):1056-61. PubMed ID: 17685742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Omega-3 Fatty Acids on Depressive Symptoms in HIV-Positive Individuals: A Randomized, Placebo-Controlled Clinical Trial.
    Ravi S; Khalili H; Abbasian L; Arbabi M; Ghaeli P
    Ann Pharmacother; 2016 Oct; 50(10):797-807. PubMed ID: 27323793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lamotrigine in the treatment of mental disorders].
    Malt UF; Fladvad T
    Tidsskr Nor Laegeforen; 2001 May; 121(12):1473-7. PubMed ID: 11449770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study).
    Marwood L; Taylor R; Goldsmith K; Romeo R; Holland R; Pickles A; Hutchinson J; Dietch D; Cipriani A; Nair R; Attenburrow MJ; Young AH; Geddes J; McAllister-Williams RH; Cleare AJ
    BMC Psychiatry; 2017 Jun; 17(1):231. PubMed ID: 28651526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression--The EMC trial.
    Tadić A; Wachtlin D; Berger M; Braus DF; van Calker D; Dahmen N; Dreimüller N; Engel A; Gorbulev S; Helmreich I; Kaiser AK; Kronfeld K; Schlicht KF; Tüscher O; Wagner S; Hiemke C; Lieb K
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):705-16. PubMed ID: 26899588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports.
    Karadağ F; Tan D; Unal F
    Turk Psikiyatri Derg; 2011; 22(4):269-72. PubMed ID: 22143953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.
    Manning JS; Haykal RF; Connor PD; Cunningham PD; Jackson WC; Long S
    J Affect Disord; 2005 Feb; 84(2-3):259-66. PubMed ID: 15708424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium augmentation of venlafaxine in adolescent major depression.
    Walter G; Lyndon B; Kubb R
    Aust N Z J Psychiatry; 1998 Jun; 32(3):457-9. PubMed ID: 9672738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferation.
    O'Leary OF; Zandy S; Dinan TG; Cryan JF
    Neuroscience; 2013 Jan; 228():36-46. PubMed ID: 23069753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study.
    Wozniak J; Faraone SV; Chan J; Tarko L; Hernandez M; Davis J; Woodworth KY; Biederman J
    J Clin Psychiatry; 2015 Nov; 76(11):1548-55. PubMed ID: 26646031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.